⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL1446059 | 0.86 | — | — | |
| SCHEMBL666368 | 0.81 | — | — | |
| SCHEMBL10968482 | 0.79 | POLB (0.35) | — | |
| SCHEMBL13236669 | 0.79 | ALDH1A1 (0.50) | — | |
| SCHEMBL4037683 | 0.79 | ALDH1A1 (0.50) | — | |
| SCHEMBL166418 | 0.76 | — | — | |
| SCHEMBL360815 | 0.76 | — | — | |
| SCHEMBL10512933 | 0.75 | — | — | |
| SCHEMBL13843636 | 0.75 | ALDH1A1 (0.47) | — | |
| SCHEMBL17599192 | 0.75 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 774 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-4399206-A1 | PAPD5 AND/OR PAPD7 INHIBITING 4-OXO-1,4-DIHYDROQUINOLINE-3-CARBOXYLIC ACID DERIVATIVES | Redona Therapeutics, Inc. (US) | 2024-07-17 | — | — | EP | claimed |
| CN-118201914-A | 4-Oxo-1, 4-dihydroquinoline-3-carboxylic acid derivatives as PAPD5 and/or PAPD7 inhibitors | 雷多纳治疗公司 | 2024-06-14 | — | — | CN | claimed |
| US-11802173-B2 | Voided latex particles containing functionalized outer shells | ARKEMA INC. (US) | 2023-10-31 | — | — | US | claimed |
| EP-3519471-B1 | AQUEOUS POLYMER DISPERSION AND USE THEREOF AS INK ANCHORAGE PRIMER | BASF SE (DE) | 2023-06-21 | — | — | EP | claimed |
| WO-2023039089-A1 | PAPD5 AND/OR PAPD7 INHIBITING 4-OXO-1,4-DIHYDROQUINOLINE-3-CARBOXYLIC ACID DERIVATIVES | TWENTYEIGHT-SEVEN, INC. (US) | 2023-03-16 | — | — | WO | claimed |
| US-20220098349-A1 | VOIDED LATEX PARTICLES CONTAINING FUNCTIONALIZED OUTER SHELLS | ARKEMA INC (US) | 2022-03-31 | — | — | US | claimed |
| US-11161990-B2 | Voided latex particles containing functionalized outer shells | ARKEMA INC. (US) | 2021-11-02 | — | — | US | claimed |
| CN-108174603-B | 1-heteroaryl-indoline-4-carboxamides as GPR52 modulators | 阿芮纳制药有限公司 | 2021-07-02 | — | — | CN | claimed |
| CN-107848248-B | Cavitated latex particles with functionalized shell | 阿科玛股份有限公司 | 2021-04-27 | — | — | CN | claimed |
| US-10597477-B2 | Finely divided aqueous emulsion polymers and use thereof for hydrophobic coatings | BASF SE (DE) | 2020-03-24 | — | — | US | claimed |
| US-20020094974-A1 | Compounds specific to adenosine A3 receptor and uses thereof | OSI PHARMACEUTICALS, INC. | 2002-07-18 | — | — | US | claimed |
| EP-1216243-A1 | QUINAZOLINONES AND ANALOGUES AND THEIR USE AS LOCAL ANESTHETICS | Advanced Medicine, Inc. (US) | 2002-06-26 | — | — | EP | claimed |
| WO-2001039777-A1 | COMPOUNDS SPECIFIC TO ADENOSINE A1 A2A, AND A3 RECEPTORS AND USES THEREOF | OSI PHARMACEUTICALS, INC. (US) | 2001-06-07 | — | — | WO | claimed |
| WO-2001025234-A1 | QUINAZOLINONES AND ANALOGUES AND THEIR USE AS LOCAL ANESTHETICS | ADVANCED MEDICINE, INC. (US) | 2001-04-12 | — | — | WO | claimed |
| EP-0533824-B1 | PIPERIDYL-SUBSTITUTED INDOLES | LUNDBECK & CO AS H (DK) | 1994-11-09 | — | — | EP | claimed |
| EP-0533824-A1 | PIPERIDYL-SUBSTITUTED INDOLES. | LUNDBECK & CO AS H (DK) | 1993-03-31 | — | — | EP | claimed |
| WO-1992000070-A1 | PIPERIDYL-SUBSTITUTED INDOLES | H. LUNDBECK A/S (DK) | 1992-01-09 | — | — | WO | claimed |
| EP-0131374-B1 | PROCESS AND INTERMEDIATES FOR THE PREPARATION OF PENEM DERIVATIVES | PFIZER INC. (US) | 1988-11-23 | — | — | EP | claimed |
| US-4619783-A | BACTERICIDES | PFIZER INC. (US) | 1986-10-28 | — | — | US | claimed |
| EP-0131374-A1 | Process and intermediates for the preparation of penem derivatives | PFIZER INC. (US) | 1985-01-16 | — | — | EP | claimed |